B1 - Criteria for the Choice and Definition of Healthy Volunteers and/or Patients for Phase I and II Studies in Drug Development

Main Contacts

Dr Anusha Panjwani

Science Officer anusha.panjwani@cost.eu

Ms Gabriela Cristea

Administrative Officer gabriela.cristea@cost.eu